403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Merak Capital Leads $1.65 Million Investment in Hakeem Health, Alongside Sanabil 500
(MENAFN- Edelman) Riyadh, Saudi Arabia – 10 May 2026– Merak Capital, a Saudi-based investment firm licensed by the Capital Market Authority, leads a $1.65M investment round in Hakeem Health alongside Sanabil 500. Hakeem Health is a healthcare technology company developing an AI-powered medical assistant that delivers real-time, evidence-based clinical insights at the point of care in multiple languages.
Hakeem Health’s flagship platform, HakeemDx, is a clinical decision support engine that integrates with hospital systems, including EMRs and lab platforms, to deliver real-time, bilingual (Arabic/English), evidence-based guidance to clinicians at the point of care, reducing medical errors and supporting better patient outcomes.
Operating on a scalable SaaS model, Hakeem Health is targeting institutional adoption across hospitals, universities and healthcare payers through recurring contracts. With more than 2,000 hospitals across key regional markets, including Saudi Arabia, the UAE and Egypt, the company is positioned for regional growth.
The investment aligns with Merak Capital’s strategy to support high-growth technology companies, with a focus on artificial intelligence as a driver of innovation. It also reflects the firm’s commitment to Saudi Arabia’s Vision 2030, supporting digital transformation and the development of knowledge-based industries.
Abdulelah Alshareef, Principal of Venture Capital at Merak Capital, said: “AI is already delivering measurable productivity gains across industries, and healthcare remains a critical area for impact. Hakeem addresses key challenges in clinical decision-making by enabling faster, more accurate assessments that can improve patient outcomes. Backed by a team with deep industry experience, this represents the kind of innovation we are proud to support.”
Bilal Adi, Founder and CEO of Hakeem Health, said: “Our mission is to help clinicians make better decisions, faster, so patients receive better care. Merak Capital’s investment reinforces that mission and supports the next phase of our growth. This funding enables us to expand our platform “HakeemDx” across hospitals and health systems in the GCC and continue building AI solutions that clinicians trust.”
With this investment, Hakeem Health is positioned to accelerate institutional adoption of HakeemDx across the GCC, as regional healthcare systems increasingly look to AI to drive clinical efficiency and quality of care.
Hakeem Health’s flagship platform, HakeemDx, is a clinical decision support engine that integrates with hospital systems, including EMRs and lab platforms, to deliver real-time, bilingual (Arabic/English), evidence-based guidance to clinicians at the point of care, reducing medical errors and supporting better patient outcomes.
Operating on a scalable SaaS model, Hakeem Health is targeting institutional adoption across hospitals, universities and healthcare payers through recurring contracts. With more than 2,000 hospitals across key regional markets, including Saudi Arabia, the UAE and Egypt, the company is positioned for regional growth.
The investment aligns with Merak Capital’s strategy to support high-growth technology companies, with a focus on artificial intelligence as a driver of innovation. It also reflects the firm’s commitment to Saudi Arabia’s Vision 2030, supporting digital transformation and the development of knowledge-based industries.
Abdulelah Alshareef, Principal of Venture Capital at Merak Capital, said: “AI is already delivering measurable productivity gains across industries, and healthcare remains a critical area for impact. Hakeem addresses key challenges in clinical decision-making by enabling faster, more accurate assessments that can improve patient outcomes. Backed by a team with deep industry experience, this represents the kind of innovation we are proud to support.”
Bilal Adi, Founder and CEO of Hakeem Health, said: “Our mission is to help clinicians make better decisions, faster, so patients receive better care. Merak Capital’s investment reinforces that mission and supports the next phase of our growth. This funding enables us to expand our platform “HakeemDx” across hospitals and health systems in the GCC and continue building AI solutions that clinicians trust.”
With this investment, Hakeem Health is positioned to accelerate institutional adoption of HakeemDx across the GCC, as regional healthcare systems increasingly look to AI to drive clinical efficiency and quality of care.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment